146 related articles for article (PubMed ID: 19563615)
1. Apoptosis, cell proliferation and modulation of cyclin-dependent kinase inhibitor p21(cip1) in vascular remodelling during vein arterialization in the rat.
Borin TF; Miyakawa AA; Cardoso L; de Figueiredo Borges L; Gonçalves GA; Krieger JE
Int J Exp Pathol; 2009 Jun; 90(3):328-37. PubMed ID: 19563615
[TBL] [Abstract][Full Text] [Related]
2. Vein adaptation to arterialization in an experimental model.
Westerband A; Crouse D; Richter LC; Aguirre ML; Wixon CC; James DC; Mills JL; Hunter GC; Heimark RL
J Vasc Surg; 2001 Mar; 33(3):561-9. PubMed ID: 11241128
[TBL] [Abstract][Full Text] [Related]
3. Time course of the regression of intimal hyperplasia in experimental vein grafts.
Davies MG; Fulton GJ; Svendsen E; Hagen PO
Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
[TBL] [Abstract][Full Text] [Related]
4. p27(Kip1) and p21(Cip1)-independent proliferative inhibition of vascular smooth muscle cells cultured in type-I collagen matrix honeycombs.
Uchida M; Suzuki S; Suzuki T; Ishii I
Microvasc Res; 2016 Jan; 103():36-40. PubMed ID: 26522285
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
[TBL] [Abstract][Full Text] [Related]
6. Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts.
Zhang WD; Bai HZ; Sawa Y; Yamakawa T; Kadoba K; Taniguchi K; Masuda J; Ogata J; Shirakura R; Matsuda H
J Vasc Surg; 1999 Jul; 30(1):169-83. PubMed ID: 10394167
[TBL] [Abstract][Full Text] [Related]
7. Arterialization of a vein graft promotes cell cycle progression through Akt and p38 mitogen-activated protein kinase pathways: impact of the preparation procedure.
Chung AW; Wong J; Luo H; Hsiang YN; van Breemen C; Okon EB
Can J Cardiol; 2007 Dec; 23(14):1147-54. PubMed ID: 18060101
[TBL] [Abstract][Full Text] [Related]
8. Changes in the organization of the smooth muscle cells in rat vein grafts.
Liu SQ; Fung YC
Ann Biomed Eng; 1998; 26(1):86-95. PubMed ID: 10355553
[TBL] [Abstract][Full Text] [Related]
9. Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice.
Mayr U; Mayr M; Li C; Wernig F; Dietrich H; Hu Y; Xu Q
Circ Res; 2002 Feb; 90(2):197-204. PubMed ID: 11834713
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid inhibits mesangial cell proliferation by up-regulating p21Waf1/Cip1 and p27Kip1 and down-regulating Skp2.
Su B; Chen X; Zhong C; Guo N; He J; Fan Y
J Nephrol; 2012; 25(6):1031-40. PubMed ID: 22344541
[TBL] [Abstract][Full Text] [Related]
11. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis, proliferation, and morphology during vein graft remodeling in rabbits.
Wan L; Dai SH; Lai SQ; Liu LQ; Wang Q; Xu H; Wang WJ; Liu JC
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808365
[TBL] [Abstract][Full Text] [Related]
13. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.
Takahashi A; Taniguchi T; Ishikawa Y; Yokoyama M
Circ Res; 1999 Mar; 84(5):543-50. PubMed ID: 10082476
[TBL] [Abstract][Full Text] [Related]
14. Vein graft arterialization causes differential activation of mitogen-activated protein kinases.
Saunders PC; Pintucci G; Bizekis CS; Sharony R; Hyman KM; Saponara F; Baumann FG; Grossi EA; Colvin SB; Mignatti P; Galloway AC
J Thorac Cardiovasc Surg; 2004 May; 127(5):1276-84. PubMed ID: 15115983
[TBL] [Abstract][Full Text] [Related]
15. Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits.
Furuyama T; Komori K; Shimokawa H; Matsumoto Y; Uwatoku T; Hirano K; Maehara Y
J Vasc Surg; 2006 Jun; 43(6):1249-56. PubMed ID: 16765249
[TBL] [Abstract][Full Text] [Related]
16. Prevention of focal intimal hyperplasia in rat vein grafts by using a tissue engineering approach.
Liu SQ
Atherosclerosis; 1998 Oct; 140(2):365-77. PubMed ID: 9862280
[TBL] [Abstract][Full Text] [Related]
17. Soluble Jagged-1 inhibits restenosis of vein graft by attenuating Notch signaling.
Zhou X; Xiao Y; Mao Z; Huang J; Geng Q; Wang W; Dong P
Microvasc Res; 2015 Jul; 100():9-16. PubMed ID: 25660475
[TBL] [Abstract][Full Text] [Related]
18. Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase.
West N; Guzik T; Black E; Channon K
Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):189-94. PubMed ID: 11156851
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha and the early vein graft.
Jiang Z; Shukla A; Miller BL; Espino DR; Tao M; Berceli SA; Ozaki CK
J Vasc Surg; 2007 Jan; 45(1):169-76. PubMed ID: 17210403
[TBL] [Abstract][Full Text] [Related]
20. Reduced patency in left-sided arteriovenous grafts in a porcine model.
Liu S; Wang T; Wang J; Isaji T; Ono S; Fereydooni A; Taniguchi R; Matsubara Y; Niklason LE; Dardik A
J Vasc Surg; 2020 Jul; 72(1):305-317.e6. PubMed ID: 31699515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]